IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Zafgen Inc. and Encourages Investors to Contact the Firm (ZFGN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Zafgen Inc. and Encourages Investors to Contact the Firm (ZFGN)

Cowen Cuts Price Target on Zafgen (ZFGN) as Beloranib is Placed on Hold Following Patient Death

October 16, 2015 1:28 PM EDT

Cowen reiterated an Outperform rating on Zafgen (NASDAQ: ZFGN), and cut the price target to $20.00 (from $60.00), following FDA'a decision to place beloranib on a partial clinical hold. Late yesterday ZFGN received verbal notice from the FDA that beloranib has been placed on partial... More